Prime medicine to participate in upcoming investor conferences

Cambridge, mass., feb. 28, 2024 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in two upcoming conferences:
PRME Ratings Summary
PRME Quant Ranking